Davenport & CO LLC Pds Biotechnology Corp Transaction History
Davenport & CO LLC
- $17.6 Billion
- Q4 2025
A detailed history of Davenport & CO LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Davenport & CO LLC holds 10,000 shares of PDSB stock, worth $8,500. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$8,500% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PDSB
# of Institutions
52Shares Held
5.46MCall Options Held
247KPut Options Held
0-
Vanguard Group Inc Valley Forge, PA1.9MShares$1.62 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$413,9210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA482KShares$409,6990.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il386KShares$328,4650.0% of portfolio
-
Squarepoint Ops LLC New York, NY292KShares$247,8820.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $24.2M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...